Skip to main content
. 2021 Sep 18;191(4):1931–1936. doi: 10.1007/s11845-021-02740-x

Table 3.

Prognostic factors affecting mortality

Variables No mortality Yes mortality p-value
N (number of patients) % N (number of patients) %
Gender Male 14 82.4 71 66.4 0.187
Female 3 17.6 36 33.6
Age  < 65 11 64.7 48 44.9 0.13
 > 65 6 35.3 59 55.1
Cigarette Yok 14 82.4 29 27.1  < 0.001
Var 3 17.6 78 72.9
Age (year) Mean ± StD 59.5 ± 17.2 66.2 ± 11.6 0.142
Pneumothorax side Right 14 82.4 68 63.6 0.237
Left 3 17.6 29 27.1
Bilateral 0 0 10 9.3
Tube thoracostomy No 2 11.8 9 8.4 0.651
Yes 15 88.2 98 91.6
CCI 0–3 9 52.9 25 23.4 0.011
 > 4 8 47.1 82 76.6
NLR Median 12.5 16.9 0.012
WBC Median 12.6 11.0 0.785
CRP Median 89.1 106.7 0.362
IL-6 Median 24.6 53.4 0.017
SII Median 3174.2 4105.6 0.100
Prognosis Middle 4 23.5 9 8.4 0.059
Serious 13 76.5 98 91.6

CCI Charlson Comorbidity Index, NLR neutrophil–lymphocyte ratio, WBC white blood cell, CRP C-reactive protein, IL-6: interlockin-6, SII Systemic Immune Inflammation Index, StD standard deviation